Literature DB >> 19920187

Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ.

Christopher Jedeszko1, Bernadette C Victor, Izabela Podgorski, Bonnie F Sloane.   

Abstract

Stromal-derived hepatocyte growth factor (HGF) acting through its specific proto-oncogene receptor c-Met has been suggested to play a paracrine role in the regulation of tumor cell migration and invasion. The transition from preinvasive ductal carcinoma in situ (DCIS) to invasive breast carcinoma is marked by infiltration of stromal fibroblasts and the loss of basement membrane. We hypothesized that HGF produced by the infiltrating fibroblasts may alter proteolytic pathways in DCIS cells, and, to study this hypothesis, established three-dimensional reconstituted basement membrane overlay cocultures with two human DCIS cell lines, MCF10.DCIS and SUM102. Both cell lines formed large dysplastic structures in three-dimensional cultures that resembled DCIS in vivo and occasionally developed invasive outgrowths. In coculture with HGF-secreting mammary fibroblasts, the percentage of DCIS structures with invasive outgrowths was increased. Activation of c-Met with conditioned medium from HGF-secreting fibroblasts or with recombinant HGF increased the percentage of DCIS structures with invasive outgrowths, their degradation of collagen IV, and their secretion of urokinase-type plasminogen activator and its receptor. In agreement with the in vitro findings, coinjection with HGF-secreting fibroblasts increased invasiveness of MCF10.DCIS xenografts in severe combined immunodeficient mice. Our study shows that paracrine HGF/c-Met signaling between fibroblasts and preinvasive DCIS cells enhances the transition to invasive carcinomas and suggests that three-dimensional cocultures are appropriate models for testing therapeutics that target tumor microenvironment-enhanced invasiveness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19920187      PMCID: PMC2789178          DOI: 10.1158/0008-5472.CAN-09-1043

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

1.  MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ.

Authors:  F R Miller; S J Santner; L Tait; P J Dawson
Journal:  J Natl Cancer Inst       Date:  2000-07-19       Impact factor: 13.506

Review 2.  The microenvironment of the tumour-host interface.

Authors:  L A Liotta; E C Kohn
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

3.  Expression of the hepatocyte growth factor/c-Met pathway is increased at the cancer front in breast carcinoma.

Authors:  G Edakuni; E Sasatomi; T Satoh; O Tokunaga; K Miyazaki
Journal:  Pathol Int       Date:  2001-03       Impact factor: 2.534

Review 4.  Putting tumours in context.

Authors:  M J Bissell; D Radisky
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

5.  ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini.

Authors:  S K Muthuswamy; D Li; S Lelievre; M J Bissell; J S Brugge
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

Review 6.  The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer.

Authors:  Bruce E Elliott; Wesley L Hung; Alexander H Boag; Alan B Tuck
Journal:  Can J Physiol Pharmacol       Date:  2002-02       Impact factor: 2.273

7.  Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion.

Authors:  E C Koon; P C Ma; R Salgia; W R Welch; J G Christensen; R S Berkowitz; S C Mok
Journal:  Int J Gynecol Cancer       Date:  2007-11-16       Impact factor: 3.437

8.  Fibroblast-dependent differentiation of human microvascular endothelial cells into capillary-like 3-dimensional networks.

Authors:  Omaida C Velazquez; Ruthanne Snyder; Zhao-Jun Liu; Ronald M Fairman; Meenhard Herlyn
Journal:  FASEB J       Date:  2002-06-07       Impact factor: 5.191

9.  The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells.

Authors:  M Simian; Y Hirai; M Navre; Z Werb; A Lochter; M J Bissell
Journal:  Development       Date:  2001-08       Impact factor: 6.868

10.  Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET.

Authors:  Wen G Jiang; David Grimshaw; Tracey A Martin; Gaynor Davies; Christian Parr; Gareth Watkins; Jane Lane; Roger Abounader; John Laterra; Robert E Mansel
Journal:  Clin Cancer Res       Date:  2003-09-15       Impact factor: 12.531

View more
  62 in total

Review 1.  Pathomimetic cancer avatars for live-cell imaging of protease activity.

Authors:  Kyungmin Ji; Joshua Heyza; Dora Cavallo-Medved; Bonnie F Sloane
Journal:  Biochimie       Date:  2015-09-12       Impact factor: 4.079

2.  Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix.

Authors:  Yekaterina B Khotskaya; Benjamin H Beck; Douglas R Hurst; Zhenbo Han; Weiya Xia; Mien-Chie Hung; Danny R Welch
Journal:  Mol Carcinog       Date:  2013-09-02       Impact factor: 4.784

Review 3.  Insidious changes in stromal matrix fuel cancer progression.

Authors:  Fayth L Miles; Robert A Sikes
Journal:  Mol Cancer Res       Date:  2014-01-22       Impact factor: 5.852

4.  MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression.

Authors:  Mansoureh Sameni; Arulselvi Anbalagan; Mary B Olive; Kamiar Moin; Raymond R Mattingly; Bonnie F Sloane
Journal:  J Vis Exp       Date:  2012-02-17       Impact factor: 1.355

5.  Cancer associated fibroblasts: the dark side of the coin.

Authors:  Paolo Cirri; Paola Chiarugi
Journal:  Am J Cancer Res       Date:  2011-03-12       Impact factor: 6.166

6.  Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.

Authors:  Mansoureh Sameni; Elizabeth A Tovar; Curt J Essenburg; Anita Chalasani; Erik S Linklater; Andrew Borgman; David M Cherba; Arulselvi Anbalagan; Mary E Winn; Carrie R Graveel; Bonnie F Sloane
Journal:  Clin Cancer Res       Date:  2015-10-02       Impact factor: 12.531

7.  3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment.

Authors:  Kamiar Moin; Mansoureh Sameni; Bernadette C Victor; Jennifer M Rothberg; Raymond R Mattingly; Bonnie F Sloane
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

Review 8.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

9.  A microengineered pathophysiological model of early-stage breast cancer.

Authors:  Yoonseok Choi; Eunjeh Hyun; Jeongyun Seo; Cassidy Blundell; Hee Chan Kim; Eunhee Lee; Su Hyun Lee; Aree Moon; Woo Kyung Moon; Dongeun Huh
Journal:  Lab Chip       Date:  2015-08-21       Impact factor: 6.799

Review 10.  Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ.

Authors:  Hitchintan Kaur; Shihong Mao; Seema Shah; David H Gorski; Stephen A Krawetz; Bonnie F Sloane; Raymond R Mattingly
Journal:  Expert Rev Mol Diagn       Date:  2013-03       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.